ReviewDiagnostics (Basel, Switzerland)2021

Point Mutation Specific Antibodies in B-Cell and T-Cell Lymphomas and Leukemias: Targeting IDH2, KRAS, BRAF and Other Biomarkers RHOA, IRF8, MYD88, ID3, NRAS, SF3B1 and EZH2.

Kunwar Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.